chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received his 1st Pfizer covid vaccine dose on 04Aug2021 and then was diagnosed with Covid-19 on 10Aug2021; This is a spontaneous report from a contactable consumer (patient). A 42-year-old male patient (consumer) received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot Number: EW0171 and expiration date was not provided), dose 1 via an unspecified route of administration, administered in Arm Left on 04Aug2021 14:00 (age 42-year-old at the time of vaccination) as DOSE 1, SINGLE for covid-19 immunisation. The patient's relevant medical history included blood pressure high and ulcer from an unspecified date and ongoing. The concomitant medications included Hydrochlorothiazide at 25mg once daily from an unspecified date and ongoing for blood pressure high, Amlodipine at 5mg once a day from an unspecified date and ongoing for blood pressure high, Pantoprazole 1 tablet once daily from an unspecified date and ongoing for Ulcer. No prior vaccinations/other vaccinations within four weeks prior to the first administration date of the suspect vaccine was given. The patient stated that people came to his job and gave him the shot of Pfizer Covid 19 vaccine on 04Aug2021, then he got Corona, so he missed his second dose. The received his first Pfizer covid vaccine dose on 04Aug2021 and then was diagnosed with Covid-19 on 10Aug2021. Today, on 25Aug2021, he was supposed to get his second Comirnaty dose and could not be due to quarantine x 14 days plus 3 days extra. The patient asked when he could get it and if he could still get it at his job. He went to his doctor's office, who did the Covid test, which came back positive. No treatment was prescribed, he was just told to quarantine for 14 days, but he had to go an extra 3 days because his daughter got Covid too. The patient declined to provide email address. The patient underwent lab tests and procedures which included sars-cov-2 test which was found to be positive for Covid 19 on 10Aug2021. The outcome of the event was reported as not recovered.   Follow-up attempts are completed. No further information is expected.
Rash developed 2 weeks after vaccine. Rash was described as raised and itchy around injection site.
My right leg, hip and groin all hurt all the time, it is very bad pain all the way down that leg. This has been going on since May 23rd, 2021 and is till happening. My dr is having me go to PT soon.  Also about three weeks ago I am now having hot flashes.
felt like she had a minor case of the flu; runny nose; aches; pains; headache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (felt like she had a minor case of the flu), RHINORRHOEA (runny nose), PAIN (aches), PAIN (pains) and HEADACHE (headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Kidney failure.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced INFLUENZA (felt like she had a minor case of the flu), RHINORRHOEA (runny nose), PAIN (aches), PAIN (pains) and HEADACHE (headache). On 23-Mar-2021, RHINORRHOEA (runny nose) outcome was unknown. At the time of the report, INFLUENZA (felt like she had a minor case of the flu), PAIN (aches), PAIN (pains) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2020, SARS-CoV-2 test: negative Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Feb 26: 4 hours after injection severe left arm pain beginning at injection site then spreading down arm. Fatigue. General sense of feeling out of it. Painful cramp, fever feeling throughout body. Right ankle became painful. Resolved w/in 15 hours of injection.  Mar. 5: Woke up with moderate left arm pain, muscle soreness. Pain increased throughout day, but less severe than pain experienced after injection. Progressed to shoulder and left back pain. Spread to hands. Left leg had slight cramping. Resolved w/in 24 hours.
Redness and swelling of left arm below injection site. Patient states reaction has lessened in severity over last two days.
Hot flashes; Case reference number US-BN-2021-002161 is a spontaneous case report initially received from a consumer via Agency (reference number: USBAV21-0409) on 12-Aug-2021 and concerns a 58-year-old female patient.  The patient's historical condition included hysterectomy. The patient's current condition included postmenopausal symptoms.  The patient's concomitant medication details were not provided.  On 12-Jun-2021, the patient was vaccinated with first dose of RabAvert (Inactivated Rabies Virus Vaccine; batch number: not provided), at a dose reported as 'standard', administered intramuscularly for post-exposure.   On the same date, the patient experienced hot flashes.   On 15-Jun-2021, the patient was vaccinated with second dose of RabAvert (Inactivated Rabies Virus Vaccine; batch number: not provided), at a dose reported as 'standard', administered intramuscularly for post-exposure.   On 19-Jun-2021, the patient was vaccinated with third dose of RabAvert (Inactivated Rabies Virus Vaccine; batch number: not provided), at a dose reported as 'standard', administered intramuscularly for post-exposure.   On 26-Jun-2021, the patient was vaccinated with fourth dose of RabAvert (Inactivated Rabies Virus Vaccine; batch number: not provided), at a dose reported as 'standard', administered intramuscularly for post-exposure.   The reporter stated that all four vaccinations were done by the emergency room and that hot flashes were under control before this series of vaccines.  At the time of this report, the outcome of the event 'hot flashes' was unknown. However, it was also reported that the stop date of the event was 26-Jun-2021 (pending query).  The reporter assessed the event as non-serious. The reporter did not provide causality assessment.    No further information was provided.; Reporter's Comments: Hot flush is unlisted for RabAvert according to to the  Information. Reportedly, the patient was vaccinated with first dose of RabAvert and on the same day experienced hot flashes. The temporal relationship is considered plausible. The patient's current condition of postmenopausal symptoms could have contributed in development of the event. However, as temporal relationship is suggestive, the causality is assessed as possibly related to RabAvert.; Sender's Comments: Hot flush is unlisted for RabAvert according to to the Information. Reportedly, the patient was vaccinated with first dose of RabAvert and on the same day experienced hot flashes. The temporal relationship is considered plausible. The patient's current condition of postmenopausal symptoms could have contributed in development of the event. However, as temporal relationship is suggestive, the causality is assessed as possibly related to RabAvert.
Adverse event #1: Numbness of the fingertips on both hands.  Ingested one tablet of Tylenol.  Fingertips return to normal about 60 minutes thereafter. Adverse event #2: Prickly sensation on the left side of the tongue only.   No treatment.  Prickly sensation on the left side of the tongue subsided after 75 minutes.
This spontaneous report as received from a physician refers to a unspecified number of patients of unknown age. The unspecified patients medical history was not reported. The physician stated that her refrigerator and freezer units began to have temperature excursions as of 05-MAY-2014. PNEUMOVAX 23 was improperly exposed to 29F for multiple unspecified excursions (many more than 2 cycles into the freezing range) since 05-MAY-2014 and also to 49F for 12 hours. On unspecified dates since 05-MAY-2014, an unspecified number of patients received PNEUMOVAX 23 which was improperly stored. No product complaint was reported for PNEUMOVAX 23. This case is linked to 1411USA004432, 1411USA004433, 1411USA004434, 1411USA004435, 1411USA004436, 1411USA004437, 1411USA004438, 1411USA004439, 1411USA004440, 1411USA004441 and 1411USA004442 (same reporter link). Additional information has been requested.
By error the nurse administered Jynneos vaccine beyond use date to 6 patients; Case reference number US-BN-2022-004310 is a spontaneous case report initially received on 24-Oct-22 from health care professional via Communications (reference: USBAV22-1762) and concerns a patient of unknown age and gender.  The patient's medical history and concomitant medications details were not provided.  On 21-Oct-2022, six patients were vaccinated with a dose of Jynneos vaccine (smallpox and monkeypox vaccine, live, nonreplicating; batch number: FPD00013, Expiration date: Sept,2024) at an unknown dose, through unknown route of administration, at unknown anatomical location, for monkeypox prophylaxis.  On the same day, as reported by error, the nurse took the box that had a beyond use date of October 18, 2022, and administrated six doses to patients, (explicitly coded as 'Expired product administered'). Vials were not punctured prior to administration.  As reported, patients have not reported any adverse events.  The Reporter did not assess the event per seriousness criteria and assessed causality between the event and Jynneos as possible related.  This case is linked with the case US-BN-2022-004306, US-BN-2022-004307, US-BN-2022-004308, US-BN-2022-004309 and US-BN-2022-004311 (same reporter).  Additional information received from on 31-Oct-2022 included local case ID.; Reporter's Comments: Six patients of unknown demographics were vaccinated with vials of Jynneos which were 3 days past the beyond-use date, which is considered expired product administered. No adverse events were reported. Expired product administered is considered listed per company convention. No medical history or concomitant medications information was reported. The event is considered not related to Jynneos, but to human error. The case is non-serious.; Sender's Comments: Six patients of unknown demographics were vaccinated with vials of Jynneos which were 3 days past the beyond-use date, which is considered expired product administered. No adverse events were reported. Expired product administered is considered listed per company convention. No medical history or concomitant medications information was reported. The event is considered not related to Jynneos, but to human error. The case is non-serious.
Chills, muscle aches/pain, joint pain, sore arm with movement on injection arm
Developed pallor and profuse diarrhea on 1/26/08. Seen at Hospital. 1/26/08 at 23:31. Pale, hypotensive, and in shock with massive non-bloody diarrhea. Intubated and fluid resuscitation performed. Stabilized and transferred to Medical Center pediatric intensive care unit 1/27/08 AM. Still there as of 01/28/08 9am HST. 1/29/08-records received for DOS 12/13/07 well baby visit. URI, acute. Visit 1/26/08-ED note C/O diarrhea. Dry cough, copious diarrhea, pale. Eating well. Fussy, stool yellow watering. Tachypneic and dusky, decreased bowel sound, abdomen firm.  Intubated.   2/11/08-records received for DOS 1/27-2/1/08-DC DX: Shock with Respiratory Failure, requiring mechanical ventilation. Metabolic acidosis. Diarrhea. Rotavirus positive. umbilical hernia. Vomiting. Presented with 1 day history of cough and diarrhea. Increased volume of stool but no fever, vomiting, hematochezia or change in activity. In ED appeared dusky, tachycardic and irritable with distended abdomen, sunken fontanelle and poor peripheral perfusion.
Approximately 15 minutes after receiving the vaccination, pt came from our waiting area and said he was having trouble breathing and his hands were shaking. I had the patient sit down and he and I both agreed the pt was having an anxiety attack. No treatment was given. paramedics were called at [patients request.
Received immunizations on 10/10/01 and presented on 10/11/01 to ER with asystole and was unable to revive.
Patient complained of redness, swelling and tenderness at injection site in Left arm. Patient was treated with Keflex 500 mg every 12 hours for 7 days. Apply ice to the site and take 600 mg of Ibuprofen for pain.
Received a flu shot--Influenza Virus Vaccine - Fluzone and within 24 hours of shot, the soreness went away, but was replaced by muscle pain and an uneven reddened area appeared below the site, approximately 3-4" in length and widened throughout 11/01/02. Saw medical doctor who prescribed Keflex
Information has been received from a registered nurse, a physician and the patient's mother concerning a 13 year old female patient with attention deficit/hyperactivity disorder (ADHD) and a history of headaches in the past and no known drug allergies (NKDA) who on 29-MAR-2007, 27-JUN-2007 and 13-JUN-2011 ("yesterday") was vaccinated with the first, second and third dose of GARDASIL (lot#: 656049/0187U, 657868/0523U and 668554/0306AA respectively) (dose and route not reported) respectively. Concomitant therapy included TENEX and FOCALIN for the treatment of attention deficit/hyperactivity disorder (ADHD). No other vaccines were given concomitantly with the third dose of GARDASIL. The physician reported that on 13-JUN-2011 ("yesterday") the patient experienced severe headache, fever of 103 degrees, nausea, vomiting, and tingling of toes and hands just a few hours after the injection. The mother also reported that her daughter experienced vision problems and confusion. The patient did not have a reaction after dose 1 or dose 2. The registered nurse reported that in early hours on 14-JUN-2011 the patient went to the emergency room where she was given IV hydration, IV TORADOL, FORADIL and IV ZOFRAN and neurological examination and blood work were normal. The patient remarkably improved and released. The patient was not admitted to the hospital. The emergency room physician believed this was a care of meningitis and offered a lumbar test. However the patient's mother declined to have the test done. After leaving the emergency room, symptoms returned and a call was made to the physicians' office. The patient was seen later in the day on 14-JUN-2011. By the time of visit, the patient had recovered again. No lumbar puncture was performed as there was no longer suspicion of meningitis. Other lab diagnostics studies included complete blood cell count, a urine test at the office and they took blood samples at the hospital, but the tests were not specified. The outcome of the vision problems and confusion were not reported. The reporting physician considered the severe headache, nausea, vomiting, fever of 103 degrees and tingling of toes and hands to be other important medical events because the patient required "hydration". No further information is available.
At 9:30 pm, I started feeling achy-like chills. At about 12 am, I checked my temperature and had a low-grade fever of 100.6. I took Tylenol. It was difficult to sleep. Next day on 4/18/2021, I was still achy but no fever. Very sleepy. The next morning, Monday 4/19/2021, I felt much better (besides pain where I received the vaccine).
Possible administered a 3rd full dose; Back hurt; Felt like he swallowed a bowl of nickle after vaccine; Very sick; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back hurt), DYSGEUSIA (Felt like he swallowed a bowl of nickle after vaccine), ILLNESS (Very sick) and EXTRA DOSE ADMINISTERED (Possible administered a 3rd full dose) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A, 028A21A and 007M20A) for COVID-19 vaccination.     No Medical history information was reported.  Concomitant products included APIXABAN (ELIQUIS), CLOPIDOGREL BISULFATE (PLAVIX), ATORVASTATIN CALCIUM (LIPITOR) and AMLODIPINE for an unknown indication.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In October 2021, the patient experienced BACK PAIN (Back hurt), DYSGEUSIA (Felt like he swallowed a bowl of nickle after vaccine) and ILLNESS (Very sick). On 23-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXTRA DOSE ADMINISTERED (Possible administered a 3rd full dose). On 23-Oct-2021, EXTRA DOSE ADMINISTERED (Possible administered a 3rd full dose) had resolved. At the time of the report, BACK PAIN (Back hurt) and DYSGEUSIA (Felt like he swallowed a bowl of nickle after vaccine) had not resolved and ILLNESS (Very sick) outcome was unknown.            No treatment information was reported. The patient had stated that he was taking another blood pressure medication before he had the vaccination.   This case was linked to MOD-2021-362185 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-Oct-2021: Follow-up received include no new information.
Swollen, reddened and bruised left arm. No treatment at time of this reporting.
Cannot feel anything; Left side of nose and cheek get numb; This spontaneous case was reported by a consumer and describes the occurrence of SENSORY LOSS (Cannot feel anything) and HYPOAESTHESIA (Left side of nose and cheek get numb) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SENSORY LOSS (Cannot feel anything) and HYPOAESTHESIA (Left side of nose and cheek get numb). At the time of the report, SENSORY LOSS (Cannot feel anything) and HYPOAESTHESIA (Left side of nose and cheek get numb) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  It was reported that patient did her cosmetic filler on 08 APR 2021, after that suddenly her left side of nose and cheek get numb, she could not feel anything at that time. I t was reported that she had to go through stroke evaluation.  No treatment information was reported.
Fever; Body aches; Head ache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), MYALGIA (Body aches) and HEADACHE (Head ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), MYALGIA (Body aches) and HEADACHE (Head ache). At the time of the report, PYREXIA (Fever), MYALGIA (Body aches) and HEADACHE (Head ache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication information was reported. No treatment medications were provided.
I felt unwell the next day; General body pain; This case was reported by a consumer via interactive digital media and described the occurrence of malaise in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (Family History) (Parents and sister).   On 8th June 2022, the patient received the 2nd dose of Shingles vaccine. On 9th June 2022, 1 days after receiving Shingles vaccine, the patient experienced malaise and general body pain. On an unknown date, the outcome of the malaise and general body pain were unknown.   It was unknown if the reporter considered the malaise and general body pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 9-JUN-2022 Reporter's Comments: This case was received from the patient via interactive digital media. The patient felt unwell the next day and had general pain in the body and stated it was preferable to acquiring this disease.  The patient stated about shingles as it was very painful and depending on the part of your body that hits, it was more complicated. The patient was happy to have the opportunity to be vaccinated now, since this disease was hereditary and the patient's parents and sister already had it and they suffered a lot, it was very painful.  Additional Supportive Information: Follow up would not be possible as no  contact details were available.
4 of 44 pts recvd vax & exp severe abdo pain, nausea, vomiting, diarrhea; Events occurred between 5 & 6 hrs p/vax;
More than 24 hours after receiving vaccines Patient began vomiting and fever. He was seen at facility who diagnosed him with gastroenteritis. Mom stated that this lasted a few hours.
Shingles Rash - Extreme pain, blistering rash on left chest.
About 5 days after vaccine came down with ear ache; Other vaccine same date dose number=4, lot number=fk9894; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 73-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 08Sep2022 as dose 5 (booster), single (Lot number: gh9694) at the age of 73 years, in left arm for COVID-19 immunisation; BNT162b2 (BNT162B2), on 08Sep2022 as dose 4 (booster), single (Lot number: fk9894) at the age of 73 years, in left arm for COVID-19 immunisation. The patient's relevant medical history included: "Heart failure" (unspecified if ongoing); "CKD" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: COVID-19 vaccine (Primary immunization complete; Unknown Manufacturer), for COVID-19 Immunization. The following information was reported: WRONG PRODUCT ADMINISTERED (non-serious) with onset 08Sep2022, outcome "unknown", described as "Other vaccine same date dose number=4, lot number=fk9894"; EAR PAIN (non-serious) with onset 13Sep2022, outcome "recovering", described as "About 5 days after vaccine came down with ear ache". The event "about 5 days after vaccine came down with ear ache" required physician office visit. Therapeutic measures were taken as a result of ear pain.  Additional information: The patient had no other vaccine in four weeks and was taking multiple other medications in two weeks. The patient received Amoxicline 870mg as treatment for the events. The patient had no COVID prior vaccination, was not tested for COVID post vaccination, and had no known allergies.  Follow-up attempts are completed. No further information is expected.